血液透析患者血磷检测时机与生存率:COSMOS研究
COSMOS研究纳入6797例CKD 5D期血液透析患者,比较周中与周末后采血对血磷水平及其与死亡率关系的影响。结果显示周末后采血者平均血磷更高(5.5±1.4 vs 5.2±1.4 mg/dL,P<0.001),且最低死亡风险的血磷范围上限存在显著差异(P=0.021)。提示临床指南应依据采血时机推荐血磷靶目标。
要点
- 周末后采血者平均血磷高于周中采血者(5.5±1.4 vs 5.2±1.4 mg/dL,P<0.001)。
- 最低死亡风险血磷范围:周中3.5-4.9 mg/dL,周末后3.8-5.7 mg/dL。
- 血磷靶目标上限因采血时机不同而显著差异(P=0.021)。
核心结论
- 周中与周末后采血的血磷水平及其最低死亡风险靶范围不同,指南推荐血磷靶目标时应考虑采血时机。
研究设计与样本
- COSMOS为多中心观察性研究,纳入6797例CKD 5D期血液透析患者,按周中或周末后采血分组。
- 采用单因素和多因素Cox模型,校正人口学、合并症、治疗及生化参数,基线及每6个月收集数据共3年。
主要发现
- 周末后采血者平均血磷高于周中采血者(5.5±1.4 vs 5.2±1.4 mg/dL,P<0.001)。
- 血钙和甲状旁腺激素水平在两组间无差异。
- 最低死亡风险(HR≤1.1)血磷范围:周中3.5-4.9 mg/dL(95%CI 2.9-5.2),周末后3.8-5.7 mg/dL(95%CI 3.0-6.4),上限差异显著(P=0.021)。
关键数值与推荐
- 最低死亡风险血磷范围周中为3.5-4.9 mg/dL(95%CI 2.9-5.2 mg/dL)。
- 最低死亡风险血磷范围周末后为3.8-5.7 mg/dL(95%CI 3.0-6.4 mg/dL)。
- 两组血磷范围上限差异有统计学意义(P=0.021)。
临床怎么用
- 解读血磷水平时应明确采血时机(周中或周末后),避免统一靶目标。
- 制定血磷控制策略时需结合透析间期长度个体化调整。
- 临床指南更新血磷靶目标时应按采血时机分层推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Serum phosphate is a key parameter in the management of chronic kidney disease-mineral and bone disorder (CKD-MBD). The timing of phosphate measurement is not standardized in the current guidelines. Since the optimal range of these biomarkers may vary depending on the duration of the interdialytic interval, in this analysis of the Current management of secondary hyperparathyroidism: a multicentre observational study (COSMOS), we assessed the influence of a 2- (midweek) or 3-day (post-weekend) dialysis interval for blood withdrawal on serum levels of CKD-MBD biomarkers and their association with mortality risk. METHODS: The COSMOS cohort (6797 patients, CKD Stage 5D) was divided into two groups depending upon midweek or post-weekend blood collection. Univariate and multivariate Cox's models adjusted hazard ratios (HRs) by demographics and comorbidities, treatments and biochemical parameters from a patient/centre database collected at baseline and every 6 months for 3 years. RESULTS: There were no differences in serum calcium or parathyroid hormone levels between midweek and post-weekend patients. However, in post-weekend patients, the mean serum phosphate levels were higher compared with midweek patients (5.5 ± 1.4 versus 5.2 ± 1.4 mg/dL, P < 0.001). Also, the range of serum phosphate with the lowest mortality risk [HR ≤ 1.1; midweek: 3.5-4.9 mg/dL (95% confidence interval, CI: 2.9-5.2 mg/dL); post-weekend: 3.8-5.7 mg/dL (95% CI: 3.0-6.4 mg/dL)] showed significant differences in the upper limit (P = 0.021). CONCLUSION: Midweek and post-weekend serum phosphate levels and their target ranges associated with the lowest mortality risk differ. Thus, clinical guidelines should consider the timing of blood withdrawal when recommending optimal target ranges for serum phosphate and therapeutic strategies for phosphate control.
引用
- Fernández-Martín JL, Dusso A, Martínez-Camblor P, et al. Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. Nephrol Dial Transplant. 2019. PMID: 29741651. doi:10.1093/ndt/gfy093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。